Lim YS - Search Results

1

Hepatocellular carcinoma risk in patients with chronic hepatitis B receiving tenofovir- vs. entecavir-based regimens: Individual patient data meta-analysis.

Choi WM, Yip TC, Wong GL, Kim WR, Yee LJ, Brooks-Rooney C, Curteis T, Cant H, Chen CH, Chen CY, Huang YH, Jin YJ, Jun DW, Kim JW, Park NH, Peng CY, Shin HP, Shin JW, Yang YH, Lim YS. Choi WM, et al. Among authors: lim ys. J Hepatol. 2023 Mar;78(3):534-542. doi: 10.1016/j.jhep.2022.12.007. Epub 2022 Dec 23. J Hepatol. 2023. PMID: 36572349 Free article.

2

Role of additional angiography and chemoembolization in patients with hepatocellular carcinoma who achieved complete necrosis following transarterial chemoembolization.

Jang MK, Lee HC, Kim IS, Lim YS, Chung YH, Lee YS, Sung KB, Yoon HK, Ko GY, Kim AY, Suh DJ. Jang MK, et al. Among authors: lim ys. J Gastroenterol Hepatol. 2004 Sep;19(9):1074-80. doi: 10.1111/j.1440-1746.2004.03414.x. J Gastroenterol Hepatol. 2004. PMID: 15304127 Clinical Trial.

3

Increased risk of adefovir resistance in patients with lamivudine-resistant chronic hepatitis B after 48 weeks of adefovir dipivoxil monotherapy.

Lee YS, Suh DJ, Lim YS, Jung SW, Kim KM, Lee HC, Chung YH, Lee YS, Yoo W, Kim SO. Lee YS, et al. Among authors: lim ys. Hepatology. 2006 Jun;43(6):1385-91. doi: 10.1002/hep.21189. Hepatology. 2006. PMID: 16729316

4

[Nine cases of sporadic acute hepatitis E in Korea].

Lim JW, Park CS, Ahn JM, Yu MH, Kim TS, Lim YS, Chung SW, Kim GM, Chung YH, Lee YS, Suh DJ. Lim JW, et al. Among authors: lim ys. Korean J Hepatol. 2006 Jun;12(2):230-6. Korean J Hepatol. 2006. PMID: 16804348 Korean.

5

Prevalence and risk factors of non-alcoholic fatty liver disease in potential living liver donors in Korea: a review of 589 consecutive liver biopsies in a single center.

Lee JY, Kim KM, Lee SG, Yu E, Lim YS, Lee HC, Chung YH, Lee YS, Suh DJ. Lee JY, et al. Among authors: lim ys. J Hepatol. 2007 Aug;47(2):239-44. doi: 10.1016/j.jhep.2007.02.007. Epub 2007 Mar 6. J Hepatol. 2007. PMID: 17400323

6

Neural cadherin overexpression is a predictive marker for early postoperative recurrence in hepatocellular carcinoma patients.

Seo DD, Lee HC, Kim HJ, Min HJ, Kim KM, Lim YS, Chung YH, Lee YS, Suh DJ, Yu E, Chun SY. Seo DD, et al. Among authors: lim ys. J Gastroenterol Hepatol. 2008 Jul;23(7 Pt 1):1112-8. doi: 10.1111/j.1440-1746.2007.05182.x. Epub 2007 Oct 17. J Gastroenterol Hepatol. 2008. PMID: 17944884

7

Susceptibility to type 1 autoimmune hepatitis is associated with shared amino acid sequences at positions 70-74 of the HLA-DRB1 molecule.

Lim YS, Oh HB, Choi SE, Kwon OJ, Heo YS, Lee HC, Suh DJ. Lim YS, et al. J Hepatol. 2008 Jan;48(1):133-9. doi: 10.1016/j.jhep.2007.08.019. Epub 2007 Nov 5. J Hepatol. 2008. PMID: 18022727

8

The global impact of hepatic fibrosis and end-stage liver disease.

Lim YS, Kim WR. Lim YS, et al. Clin Liver Dis. 2008 Nov;12(4):733-46, vii. doi: 10.1016/j.cld.2008.07.007. Clin Liver Dis. 2008. PMID: 18984463 Review.

9

Reappraisal of repeated transarterial chemoembolization in the treatment of hepatocellular carcinoma with portal vein invasion.

Kim KM, Kim JH, Park IS, Ko GY, Yoon HK, Sung KB, Lim YS, Lee HC, Chung YH, Lee YS, Suh DJ. Kim KM, et al. Among authors: lim ys. J Gastroenterol Hepatol. 2009 May;24(5):806-14. doi: 10.1111/j.1440-1746.2008.05728.x. Epub 2009 Jan 13. J Gastroenterol Hepatol. 2009. PMID: 19207681

10

Hepatitis B virus with the rtL80V/I mutation is associated with a poor response to adefovir dipivoxil therapy.

Lee YS, Chung YH, Kim JA, Kim SE, Shin JW, Kim KM, Lim YS, Park NH, Lee HC, Lee YS, Suh DJ. Lee YS, et al. Among authors: lim ys. Liver Int. 2009 Apr;29(4):552-6. doi: 10.1111/j.1478-3231.2008.01882.x. Liver Int. 2009. PMID: 19323782

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

802 results

Search Page